Novato, CA, United States of America

Afsaneh Rahimi-Larijani

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Bioxiness Pharmaceuticals, Inc.. Active years: 2013-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Afsaneh Rahimi-Larijani. Retrieved from https://idiyas.com/inventor/afsaneh-rahimi-larijani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Afsaneh Rahimi-Larijani: Pioneering Inventor from Novato, CA

Introduction: Afsaneh Rahimi-Larijani is a trailblazing inventor based in Novato, California, known for her innovative contributions to the field of technology and healthcare.

Latest Patents: Afsaneh Rahimi-Larijani holds several patents in the areas of medical devices, artificial intelligence, and sustainable energy solutions, showcasing her diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Afsaneh Rahimi-Larijani has led groundbreaking projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout her career, Afsaneh Rahimi-Larijani has collaborated with top research institutions, leading companies, and talented individuals to bring her ideas to life and make a lasting impact on society.

Conclusion: Afsaneh Rahimi-Larijani's dedication to innovation, coupled with her relentless drive to create a better future through her inventions, solidifies her position as a prominent figure in the world of inventors and visionaries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…